Cho, J. Y.
21329  Ergebnisse:
Personensuche X
?
2

MON-175 THE DEVELOPMENT OF ASIAN SOCIETY OF TRANSPLANTATION..:

Jeong, J.C. ; Ro, H. ; Koo, T.Y....
Kidney International Reports.  4 (2019)  7 - p. S374 , 2019
 
?
3

Are patients with mild to moderate renal impairment on metf..:

Jung, J. ; Cho, Y.Y. ; Jung, J.H....
Clinical Radiology.  74 (2019)  8 - p. 651.e1-651.e6 , 2019
 
?
4

The effects of cortisol and adrenal androgen on bone mass i..:

Ahn, S.H. ; Kim, J. H. ; Cho, Y. Y....
Osteoporosis International.  30 (2019)  5 - p. 1059-1069 , 2019
 
?
5

Intensity of surveillance for hepatocellular carcinoma dete..:

Kim, H. Y. ; Nam, J. Y. ; Lee, J.‐H....
Alimentary Pharmacology & Therapeutics.  47 (2018)  11 - p. 1490-1501 , 2018
 
?
6

Comparison of overall survival between antiviral‐induced vi..:

Cho, Y. Y. ; Lee, J.‐H. ; Chang, Y....
Journal of Viral Hepatitis.  25 (2018)  10 - p. 1161-1171 , 2018
 
?
7

Entecavir and tenofovir reduce hepatitis B virus‐related he..:

Cho, H. ; Ahn, H. ; Lee, D. H....
Journal of Viral Hepatitis.  25 (2018)  6 - p. 707-717 , 2018
 
?
9

Delayed viral suppression during antiviral therapy is assoc..:

Nam, J. Y. ; Chang, Y. ; Cho, H....
Journal of Viral Hepatitis.  25 (2018)  5 - p. 552-560 , 2018
 
?
 
?
12

A direct role for hepatitis B virus X protein in inducing m..:

Lee, H‐R. ; Cho, Y. Y. ; Lee, G. Y....
Journal of Viral Hepatitis.  25 (2018)  4 - p. 412-420 , 2018
 
?
13

Serum 25-hydroxyvitamin D cutoffs for functional bone measu..:

Lee, D. Y. ; Jee, J. H. ; Cho, Y. Y....
Osteoporosis International.  28 (2017)  4 - p. 1377-1384 , 2017
 
?
14

Rifaximin treatment is associated with reduced risk of cirr..:

Kang, S. H. ; Lee, Y. B. ; Lee, J.‐H....
Alimentary Pharmacology & Therapeutics.  46 (2017)  9 - p. 845-855 , 2017
 
?
15

Rifaximin reduces cirrhotic complications and prolongs over..:

Kang, S.H. ; Yoo, J.-J. ; Lee, J.-H....
Journal of Hepatology.  66 (2017)  1 - p. S572-S573 , 2017
 
1-15
Mehr Literatur finden